Berrih S, Safar D, Levasseur P, Gaud C, Bach J F
J Clin Immunol. 1984 Mar;4(2):92-7. doi: 10.1007/BF00915041.
The in vivo effects of corticotherapy on thymocyte subpopulations have been evaluated in patients with myasthenia gravis (MG). Ten patients receiving high-dose, long-term treatment were studied and compared with two control groups (MG untreated patients and normal age-matched subjects). In the treated group, the thymus was generally involuted; the percentage of OKT6+ or OKT4+T8+ thymocytes was profoundly decreased compared to controls. A significant percentage of OKT10 - cells was detected particularly among older patients, suggesting steroid-induced immigration. Conversely the percentage of more mature OKT3+ cells was increased. The balance between OKT4+T8- and OKT4-T8+ cells was unchanged in young patients (less than 40 years old) and increased in the older group. These data show that, as in the mouse, corticosteroids profoundly alter human thymocyte subsets.
已经在重症肌无力(MG)患者中评估了皮质激素疗法对胸腺细胞亚群的体内作用。研究了10名接受高剂量、长期治疗的患者,并与两个对照组(未经治疗的MG患者和年龄匹配的正常受试者)进行比较。在治疗组中,胸腺通常萎缩;与对照组相比,OKT6 + 或OKT4 + T8 + 胸腺细胞的百分比显著降低。特别是在老年患者中检测到相当比例的OKT10 - 细胞,提示类固醇诱导的迁移。相反,更成熟的OKT3 + 细胞的百分比增加。OKT4 + T8 - 和OKT4 - T8 + 细胞之间的平衡在年轻患者(小于40岁)中没有变化,而在老年组中增加。这些数据表明,与在小鼠中一样,皮质类固醇会深刻改变人类胸腺细胞亚群。